Background and Aims Hemodialysis is experienced as a vital need and is a heavy strain that is causing psychological distress expressed by anxiety and depression. The aim of our study was to estimate the prevalence of anxiety and depression in chronic hemodialysis patients. Method This is an observational cross-sectional study, carried out within the unit CASABLANCA CHU ibnrochd of hemodialysis in January of 2020 of 71 chronic hemodialysis patients, in collaboration with a psychiatrist, the scale of anxiety and depression (HAD) has been used to diagnose and assess the severity of anxiety and depression in this population. Results Our study included 71 chronic hemodialysis adult patients, the average age of our patients was 46.5 years, ranging from 16 to 93 years, with a sex ratio M / F 1.1, seniority average hemodialysis is 17.3 years; patients are single, married, widowed, divorced in 66%, 26%, 5% and 3% of cases, 72.5% of our patients are without profession. None of the patients is followed by a psychiatrist or under antidepressant or anxiolytic during the study, 46% of our patients have anxiety and depression with a male predominance in 56% of cases, anxiety was found in 15% of patients, 1 case of major anxiety, the average score of anxiety is 10 ± 2, depression was found in 36% of cases and 1 case of major depression, the average depression score was 11 ± 2. Conclusion Anxiety and depression are common in patients on periodic hemodialysisThese results emphasizes the importance of collaboration between nephrologists and psychiatrists in order to offer hemodialysis patients psychological support and guarantee a better quality of life.
Introduction: Community-acquired acute kidney injury (AKI) is common, but often unrecognized in resource-constrained settings. Limited lab assessments and lack of information on the prior state of kidney health contribute to this lack of recognition. In this study, we evaluated the cause of AKI in patients in whom AKI was suspected and then verified at initial presentation with point-of-care (POC) serum creatinine (sCr) testing. Methods: Patients presenting at participating community health care centers and emergency departments in Nepal, Bolivia, South Africa or Brazil with symptoms or signs associated with high/moderate risk of developing kidney disease underwent sCr POC testing. Staff at these centers were trained in the use of the POCs and also in the evaluation and management of kidney disease. Patient demographics and most likely etiology of acute kidney injury according to treating clinician judgment on presentation were recorded. Local practitioners determined if patients were to be treated locally or transferred to referral centers for more specialist management. Management was recorded as well as kidney and patient outcomes at discharge and over follow-up of up to 90 days after discharge. Results: 4319 patients were screened, and 4242 (98.2%) were enrolled (2028 Nepal, 858 Bolivia, 1173 South Africa and 183 Brazil). The screening form was completed in 4236 patients, with patient assessments 1 -3 completed in 4099, 3788 and 2432 cases respectively. Median (IQR) sCr at initial presentation was 1.40 (1.0-1.9) mg/dl and median (IQR) highest sCr during the episode was 1.43 (1.0-2.0) mg/dl. The most likely cause of kidney disease was documented in 3734 (88%) patients (Table ).The most common etiologies of AKI were infection (36.5% of cases) and hypovolaemia (18.2% of cases). Animal/insect bites caused 15.3% of cases in Brazil. The most common sites of infection causing AKI included the GI tract (35.2%), the lungs (18.2%) and the urinary tract (40.4%) in the cohort overall. Conclusions: Education of local healthcare workers twinned with the use of POC SCr testing facilitated the identification of kidney disease and its aetiology in four low-resource settings. Supporting previous data, the most common causes of kidney disease were infection and hypovolaemia, and hence AKI may be preventable and treatable with relatively simple interventions in this part of the world.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.